André Denault, MD, PhD
Montreal Heart Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name André Denault, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:15 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05450328 · Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass SeparationMontreal Heart Institute · recruiting · Right Heart Failure, Right Ventricular Dysfunction · principal investigator
- N/ANCT03656263 · The Clinical Significance of Portal Hypertension After Cardiac Surgery: a Multicenter Prospective Observational StudyMontreal Heart Institute · completed · Surgery--Complications, Congestive Heart Failure, Right Heart Failure
- N/ANCT02831907 · Portal Flow Pulsatility as a Risk Factor for Acute Kidney Injury After Cardiac SurgeryMontreal Heart Institute · completed · C.Surgical Procedure; Cardiac, Acute Kidney Injury, Postoperative Complications · principal investigator
- N/ANCT01458262 · Observational Study on the Clinical Impact of Desaturation During Liver SurgeryCentre hospitalier de l'Université de Montréal (CHUM) · completed · Cerebral Desaturation
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.